SOX9 and ductal breast carcinoma in situ: Low expression of miR-140 is observed in ERα-/basal-like ductal carcinoma in situ (DCIS) stem-like cells in comparison to normal stem cells and is reported to directly target the most significantly activated stem-cell factors, SOX9 and ALDH1 [60] (Table 1).